Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: Neuroimaging and neuropsychological outcomes

Cerebrovascular Diseases

Volumn 16, Issue 3, 2003, Pages 199-204

  Cohen, Ronald A ^a,c   Browndyke, Jeffrey N ^a   Moser, David J ^b   Paul, Robert H ^a   Gordon, Norman ^a   Sweet, Lawrence ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

Clinical trials; Cytidine diphosphate choline; Magnetic resonance imaging; Neuropsychological test; Vascular dementia

Indexed keywords

CITICOLINE;

AGED; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN; CYTIDINE DIPHOSPHATE CHOLINE; DEMENTIA, VASCULAR; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0041743070     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071116     Document Type: Article

References (29)

1. Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima M, Sakuma A: Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 1988;19:211-216.
2. Corso EA, Arena M, Ventimiglia A, Bizarro G, Campo G, Rodolico F: La CDP-cholina nelle vasculopatie cerebrali: valutazioni cliniche e di semeiologia strumentale. Clin Ter 1982;102:379-386.
3. Agnoli A, Fioravanti M, Lechner H: Efficacy of CDP-Choline in chronic cerebral vascular diseases (CCVD); in Zappia V, Kennedy EP, Nilsson BI, Galletti PV (eds): Novel Biochemical, Pharmacological, and Clinical Aspects of Cy-tidinediphosphocholine. New York, Elsevier Science, 1985.
4. Piccoli F, Battistini N, Carbonin P: CDP-choline in the treatment of chronic cerebrovasculopathies. Arch Gerontol Geriatr Suppl 1994;18:161-168.
5. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J: Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Ann NY Acad Sci 1993;695:321-323.
6. Di Perri R, Coppola G, Ambrosio LA, Grasso A, Puca FM, Rizzo M: A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. J Intern Med Res 1991;19:330-341.
7. Yasuhara M, Naito H: Characteristic actions of CDP-choline on the central nervous system. Curr Ther Res 1974;16:346-374.
8. Suryani LK, Adnjana TA, Jensen GD: Citicoline treatment of memory deficits in elderly people. Int J Geriatr Psychiatry 1988;3:235-236.
9. Spiers PA, Myers D, Gail S, Hochanadel GS, Lieberman HR, Wurtman RJ: Citicoline improves verbal memory in aging. Arch Neurol 1996;53:441-448.
10. Alvarez XA, Laredo M, Corzo D, Fernandez-Novoa L, Mouzo R, Perea JE, Daniele D, Cacabelos R: Citicoline improves memory performance in elderly subjects. Methods Find Exp Clin Pharmacol 1997;19:201-210.
11. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE: A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 1999;30:2592-2597.
12. Fioravanti M: Le cerebropatie vascolari croniche: la terapia con CDP-colina. Ann Ital Med Int 1989;3:26-31.
13. Capurso A, Capurso S, Panza F: Efficacy of cytidine diphosphate choline in patients affected by chronic cerebrovascular disease. Clin Drug Invest 1996;12:26-38.
14. Association AP: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, American Psychiatric Association, 1994.
15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
16. Greenwald BS, Kramer-Ginsberg E, Krishnan KR, Ashtari M, Auerbach C, Patel M: Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 1998;29:613-617.
17. Jenkins M, Malloy P, Salloway S, Cohen R, Rogg J, Tung G, Kohn R, Westlake R, Johnson EG, Richardson E: Memory processes in depressed geriatric patients with and without subcortical hyperintensities on MRI. J Neuroimaging 1998;8:20-26.
18. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognition state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Mattis S: Dementia Rating Scale: Professional Manual. Odessa, Psychological Assessment Resources, 1988.
20. Wechsler D: Wechsler Adult Intelligence Scale - Revised. New York, Psychological Corporation, 1981.
21. Gladsjo JA, Miller SW, Heaton RK: Norms for Letter and Category Fluency: Demographic Corrections for Age, Education, and Ethnicity. Odessa, Psychological Assessment Resources, 1989.
22. Delis D, Kramer J, Kaplan E, Ober B: Manual: California Verbal Learning Test, Adult Version. San Antonio, Psychological Corporation, 1987.
23. Wechsler D: Wechsler Memory Scale - Revised. San Antonio, Psychological Corporation, 1987.
24. Meyers JE, Meyers KR: Rey Complex Figure Test and Recognition Trial: Professional Manual. Odessa, Psychological Assessment Resources, 1989.
25. Hooper HE: The Hooper Visual Organization Test. Los Angeles, Western Psychological Services, 1983.
26. Kaplan E, Goodglass H, Weintraub S: Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
27. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery. Tucson, Neuropsychology Press, 1985.
28. Tanaka Y, Minematsu K, Hirano T, Hayashida K, Yamaguchi T: Effects of CDP-choline on dynamic changes in LCBF and cognitive function in demented subjects: An H-2(15)O-PET study. Clin Neurol 1994;34:877-881.
29. Cohen J: A power primer. Psychol Bull 1992;112:155-159.